AMERICAN VIETNAMESE BIOTECH INCORPORATION

American Vietnamese Biotech Incorporation

AMV

VN000000AMV5

Pharmaceuticals

End-of-day quote HANOI S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
3,100 ^VND	-3.13%		0.00%	-20.51%

Feb. 01	American Vietnamese Biotech Incorporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 01	American Vietnamese Biotech Incorporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

American Vietnamese Biotech Incorporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023

February 01, 2024 at 06:01 am EST

American Vietnamese Biotech Incorporation reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported revenue was VND 45,361.91 million compared to VND 58,951.81 million a year ago. Net income was VND 4,059.27 million compared to VND 1,762.52 million a year ago.

Latest news about American Vietnamese Biotech Incorporation

American Vietnamese Biotech Incorporation Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 01	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 01	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-30	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-01	CI
An unknown buyer entered into an agreement to acquire Bac Lieu High Techcare Clinic Joint Stock Company from American Vietnamese Biotech Incorporation for VND 29.4 billion.	23-06-19	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-05	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-02-01	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-03	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-05	CI
An unknown buyer acquired a 5.27% stake in American Vietnamese Biotech Incorporation (HNX : AMV) from Nguyen Thi Hien.	22-04-24	CI
American Vietnamese Biotech Incorporation agreed to acquire 75% stake in Leopard Solutions Joint Stock Company for VND 6000 million.	21-08-05	CI
American Vietnamese Biotech Incorporation announced that it has received VND 379.62045 billion in funding from Lotus Investment Management Joint Stock Company and other investors	21-02-28	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	21-02-02	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-02	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-07-31	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-04	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2019	20-01-30	CI
An undisclosed buyer acquired 5.28% stake in American Vietnamese Biotech Incorporation from Nguyen Thi Hong Hai.	19-12-01	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-10-30	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-02	CI
An undisclosed buyer acquired 8.5% stake in American Vietnamese Biotech Incorporation from Le Anh Hoi.	19-07-02	CI
American Vietnamese Biotech Incorporation announced that it expects to receive VND 280 billion in funding	19-05-25	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Full Year Ended December 31, 2018	19-04-16	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2018	19-01-15	CI
An undisclosed buyer acquired 6.59% stake in American Vietnamese Biotech Incorporation from Tran Van Tuan.	18-10-02	CI

Chart American Vietnamese Biotech Incorporation

Duration

Period

Chart American Vietnamese Biotech Incorporation

More charts

Company Profile

American Vietnamese Biotech Incorporation (AmviBiotech) is a Vietnam-based company engaged in the pharmaceutical industry. The Company is involved in the manufacture of medicines, vaccines and biological products. It is also involved in the manufacture of rapid diagnostic tests and ELISA kits, as well as the trading of other medical equipment and tools. In addition, the Company is active in the manufacture of cosmetic, soaps, detergents and other polishing and cleaning products. Its other activities include real estate trading, financial investment and the manufacture of plastic products. As of December 31, 2012, the Company had one wholly owned subsidiary named American - Vietnamese Biology Company Limited.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
AMERICAN VIETNAMESE BIOTECH INCORPORATION	-20.51%	16.04M
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B